These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17965791)

  • 1. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
    Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
    Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
    Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP.
    Anselmo AP; Cartoni C; Bellantuono P; Maurizi-Enrici R; Aboulkair N; Ermini M
    Haematologica; 1990; 75(2):155-8. PubMed ID: 1694156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal function following ABVD therapy for Hodgkin's disease.
    Kulkarni SS; Sastry PS; Saikia TK; Parikh PM; Gopal R; Advani SH
    Am J Clin Oncol; 1997 Aug; 20(4):354-7. PubMed ID: 9256888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
    van den Berg H; Furstner F; van den Bos C; Behrendt H
    Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
    van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
    J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
    Viviani S; Santoro A; Ragni G; Bonfante V; Bestetti O; Bonadonna G
    Eur J Cancer Clin Oncol; 1985 May; 21(5):601-5. PubMed ID: 2408897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of reproductive system function assessment in young men after Hodgkin's disease therapy].
    Moryl-Bujakowska A; Balwierz W; Małek A; Sztefko K
    Przegl Lek; 2010; 67(6):382-6. PubMed ID: 21344766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
    An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
    J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
    Heikens J; Behrendt H; Adriaanse R; Berghout A
    Cancer; 1996 Nov; 78(9):2020-4. PubMed ID: 8909325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma.
    Ben Arush MW; Solt I; Lightman A; Linn S; Kuten A
    Pediatr Hematol Oncol; 2000; 17(3):239-45. PubMed ID: 10779990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal function following chemotherapy for childhood Hodgkin's disease.
    Mackie EJ; Radford M; Shalet SM
    Med Pediatr Oncol; 1996 Aug; 27(2):74-8. PubMed ID: 8649323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with the gonadotropin-releasinghormone agonist buserelin to protect spermatogenesis against cytotoxic treatment in young men.
    Krause W; Pflüger KH
    Andrologia; 1989; 21(3):265-70. PubMed ID: 2476046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
    Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
    J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
    Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular dysfunction in Hodgkin's disease before and after treatment.
    Viviani S; Ragni G; Santoro A; Perotti L; Caccamo E; Negretti E; Valagussa P; Bonadonna G
    Eur J Cancer; 1991; 27(11):1389-92. PubMed ID: 1835853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
    Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
    Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
    Naccache P; Decaudin D; Koscielny S; Bendahmane B; Auger J; Munck JN
    Bull Cancer; 1996 Apr; 83(4):307-14. PubMed ID: 8680082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.